Sol-Gel Technologies Ltd. (SLGL) Financials

SLGL Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 45.3 million 6.6 million
2023-09-30 49.9 million 6.7 million
2023-06-30 55.1 million 6.8 million
2023-03-31 49.0 million 5.0 million

SLGL Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 ? ?
2023-09-30 ? ?
2023-06-30 ? ?
2023-03-31 ? ?

SLGL Net Income

No data available :(

SLGL Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 38.0 million - 1.7 million
2023-09-30 43.3 million - 1.7 million
2023-06-30 47.0 million - 569000
2023-03-31 33.7 million - 574000

SLGL Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 27.9 million
2023-09-30 27.8 million
2023-06-30 27.7 million
2023-03-31 24.9 million

SLGL Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 4.2 million 1.7 million -
2023-09-30 - 4.7 million 1.9 million -
2023-06-30 - 5.3 million 1.8 million -
2023-03-31 - 9.4 million 2.0 million -

SLGL Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 447000 -
2023-09-30 213000 4.7 million
2023-06-30 594000 5.3 million
2023-03-31 758000 9.4 million

SLGL

Price: $0.82

52 week price:
0.71
4.20

Earnings Per Share: -1.01 USD

P/E Ratio: -1.19

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 22900

Market Capitalization: 27.4 million

Links: